Senior Director, Inflammation Pipeline: Liver, Inflammation, COVID-19, and Established Products

For Current Gilead Employees and Contractors:

Please log onto your Internal Career Site to apply for this job.

At Gilead, we’re creating a healthier world for all people. For more than 35 years, we’ve tackled diseases such as HIV, viral hepatitis, COVID-19 and cancer – working relentlessly to develop therapies that help improve lives and to ensure access to these therapies across the globe. We continue to fight against the world’s biggest health challenges, and our mission requires collaboration, determination and a relentless drive to make a difference.
 

Every member of Gilead’s team plays a critical role in the discovery and development of life-changing scientific innovations. Our employees are our greatest asset as we work to achieve our bold ambitions, and we’re looking for the next wave of passionate and ambitious people ready to make a direct impact.
 

We believe every employee deserves a great leader. People Leaders are the cornerstone to the employee experience at Gilead and Kite. As a people leader now or in the future, you are the key driver in evolving our culture and creating an environment where every employee feels included, developed and empowered to fulfil their aspirations. Join Gilead and help create possible, together.

Job Description
 

Gilead's mission is to discover, develop, and deliver therapies that will improve the lives of patients with life-threatening illnesses worldwide. For over 30 years, Gilead has been a leading innovator in virology, and we developed today’s leading medicines for treating and preventing HIV and treating and curing viral hepatitis. More recently Gilead has expanded its presence in liver by acquiring a new product for the treatment of Primary Biliary Cholangitis (PBC).

As the Senior Director, Inflammation Pipeline: Liver, Inflammation, COVID-19, and Established Products, you will guide our pre-POC activities for pipeline assets across inflammation and immunology, building product profiles and business cases, and representing the market and commercial voice for pipeline molecules.

Key Responsibilities

Reporting to the Vice President, Global Commercial Liver, Inflammation, COVID-19 and Established Products, this role will support new and ongoing programs in the inflammation therapeutic area. The role will require working collaboratively in a cross-functional environment to deliver robust commercial assessments, provide commercial feedback into development programs, and to lead key initiatives in support of future products. Specific responsibilities will include:

• Lead Early Commercialization Teams and supporting Program Strategy Teams from pre-clinical stage to initiation of phase III. Support transition to inline teams for launch preparedness as programs enter late-stage development.

• Evaluate commercial opportunities and develop business cases for pre-clinical assets under development, and establish strong collaborative partnerships with R&D to ensure that plans have the potential to deliver differentiated products and commercial value

• Support the effective progression of programs through development stages by researching disease states and developing patient flows, situation assessments, target product profiles, and strategic options to maximize program value and return; ensure that early product development optimally supports long-term commercial objectives (e.g., through trial endpoints and comparators, target product profiles, and other value drivers related to product development)

• Synthesize the commercial perspectives, insights and results needed to identify and/or assess business development opportunities for potential acquisition and partnering, including proactively identifying & elevating opportunities of high commercial interest

• Lead teams to develop and leverage deep payer, provider, patient, market and competitive insights to support the creation of differentiated product and disease-state strategies that maximize program value

• P